U.S. Patient Assistance Programs
We believe that no one should go without the medicines or vaccines they need.
That is why our company’s U.S. patient assistance program, a separately incorporated nonprofit charitable organization, provides certain medicines and adult vaccines for free to eligible people who do not have prescription drug or health insurance coverage and who, without our assistance, cannot afford our medicines and vaccines.
This approach is consistent with our company’s commitment to improve access to our medicines and adult vaccines for people who need them.
More than 57 years ago, our company created our first U.S. patient assistance program (PAP) to keep affordable medicines within patients’ reach. Through these programs, we have provided more than 41.6 million free prescriptions and adult vaccines, representing a total value (at wholesale acquisition cost) of more than $7 billion.
We work to raise awareness of our patient assistance program among doctors and eligible patients via brochures and enrollment forms posted on our website and other company communications. All toll-free phone lines for our medicines and/or vaccines include an option for patients to learn about our patient assistance programs.
Medicine Assistance Tool
As a demonstration of our commitment to helping low-income, uninsured patients gain access to our medicines and adult vaccines, we also participate in PhRMA’s Medicine Assistance Tool (MAT), formerly known as the Partnership for Prescription Assistance (PPA). MAT is a search engine designed to help patients, caregivers and health care providers learn more about access resources available through the various biopharmaceutical industry programs.
MAT helps eligible patients get free or nearly free brand name medicines through a single website that provides information for and access to more than 500 public and private patient assistance programs, including approximately 200 programs offered by biopharmaceutical companies. To date, this tool has helped millions of Americans get free or reduced-cost prescription medicines.
|Patient assistance programs summary||2014||2015||2016||2017||2018|
|Patients utilizing our U.S. Patient Assistance Programs (in thousands)1||301||293||306||244||233|
|30-day prescriptions filled (in millions)||1.6||1.6||1.7||2.1||2.1|
|1 Totals represent 2014–2018 volumes of our U.S. Patient Assistance Program.|
Changes within the patient and prescription volumes for 2014–2018 are a result of periodic changes in the products covered in the U.S. Patient Assistance Programs. Product changes are due, in part, to the inclusion of new products, and as a result of company divestitures, introductions of competing products and the availability of generic alternatives.